PMGC Holdings Inc. (Nasdaq: ELAB) Secures Five-Year Royalty Stream from Elevai Skincare Sale Under Executed Payment Agreement with Longevity Health Holdings

PMGC Holdings Inc. (Nasdaq: ELAB) has executed a payment agreement with Longevity Health Holdings to convert its 5% net sales royalty from the January 2025 Elevai Skincare divestiture into scheduled monthly cash payments through August 2031. The agreement covers the 2025 royalty of $94,937 and all future royalty payments, with installments of $10,000 per month starting October 2026, interest accruing at WSJ Prime plus 1%, and mandatory prepayments triggered by capital events.